The concept of innovative medicine has repeatedly strengthened, and Lianhuan Pharmaceutical has hit the daily limit for 6 consecutive days.

The concept of innovative drugs has repeatedly strengthened, and the popular stock Lianhua Pharmaceutical has had 8 consecutive trading limit up days. Yifang Biotechnology has risen over 5%, reaching a new historical high. Lisin Pharmaceutical, Guangshengtang, Asia-Pacific Pharmaceuticals, Lizhu Group, and Anli Kang have all risen over 5%.